ESC Premium Access

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?

Event: ESC Congress 2021 - The Digital Experience
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session type: Great Debates
Date: 27 August 2021
Time: 12:00 - 12:45

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: pro.

Speaker: Doctor R. Al-Lamee (London, GB)
Thumbnail

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: con.

Speaker: Doctor D. Holmes (Rochester, US)
Thumbnail

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? – discussion.

Thumbnail

2 speakers from this session

Doctor Rasha Al-Lamee

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
9 presentations
0 follower

Doctor David Holmes

Mayo Clinic, Rochester (United States of America)
1 presentation
0 follower

Related content

ESC Premium Access

Individualized approach for patients with chronic coronary syndrome and heart failure: how close are we to identifying patient phenotypes?

4 December 2021

This platform is supported by

logo Novo Nordisk